Block.one, the corporate behind EOSIO (EOS), issued a $50,000 grant to Genobank for its open-source app on April 29. The grant is designed to facilitate nameless entry to COVID-19 testing.
Genobank introduced firstly of April that its app, Agerona, was being developed alongside the Eos-based blockchain platform, Telos.
Block.one issued the grant in partnership with its enterprise capital wing, EOS VC, and German fintech incubator, FinLab EOS VC.
Block.one invests in Eos-based COVID-19 testing app
Agerona connects customers anonymously with check suppliers of their nation. Assessments comprise distinctive barcodes that create a free and nameless account on the Telos blockchain for the person. Kits are then despatched to a verified lab for processing — with outcomes anonymously uploaded to the blockchain.
The system permits for check outcomes to then be analyzed by well being researchers, with out being tied to the identification of the people examined.
Genobank CEO Daniel Uribe said: “[W]e are grateful to have the backing and assist of Block.one’s enterprise arm EOS VC in aiding our efforts to anonymize DNA/RNA check kits (together with coronavirus) whereas empowering sufferers and customers to resolve if they need their anonymized information to be accessible to the scientific neighborhood and assist management the unfold of the coronavirus and doubtlessly contribute to a therapy.”
Block.one chief govt Brendan Blumer said: “We’ve witnessed the expansion of an open-source neighborhood whose ardour and innovation have helped to establish and resolve essential enterprise issues in sectors starting from artwork to wellness.”
Block.one invests in a number of companies preventing coronavirus
Block.one has funded a number of firms which can be engaged on options to issues referring to COVID-19. The corporate has achieved this via its partnership with the EOS VC Grants program, and its partnership with FinLab EOS VC.
The recipients embody well being and wellness platform, PUML Higher Well being, the job-listing platform, Moonlighting, and the AI service, Innoplexus.
“With the onset of pressing world points brought on by the coronavirus, it is necessary that we empower and assist the ways in which blockchain expertise is being utilized to supply options,” said Blumer.
Use-cases for blockchain highlighted amid coronavirus pandemic
Lots of the advantages of distributed ledger expertise, or DLT, have been showcased by latest initiatives responding to COVID-19.
On April 29, the UK’s Open College started testing a blockchain-based proof-of-immunity app for COVID-19. The prototype seeks to guard privateness whereas offering tamper-resistant check outcomes to confirm immunity.
On April 26, Cointelegraph reported that New York’s largest hospital community had joined IBM’s Speedy Provider Join community — a blockchain-based community for verifying suppliers of COVID-19 aid items, and connecting suppliers with purchasers.
Throughout April, ConsenSys builders engaged on Baseline Protocol have recommended a system for coronavirus contact tracing. They intention to handle potential privateness, record-falsification, and information centralization dangers recognized in proposals from Apple and Google.
